| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.
|
Nat Genet
|
2010
|
3.93
|
|
2
|
Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival.
|
PLoS One
|
2008
|
3.87
|
|
3
|
Genome-wide association studies identify four ER negative-specific breast cancer risk loci.
|
Nat Genet
|
2013
|
3.81
|
|
4
|
Detectable clonal mosaicism and its relationship to aging and cancer.
|
Nat Genet
|
2012
|
3.69
|
|
5
|
Genome-wide association analysis identifies three new breast cancer susceptibility loci.
|
Nat Genet
|
2012
|
3.20
|
|
6
|
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.
|
Hum Mol Genet
|
2012
|
2.45
|
|
7
|
Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer.
|
Cancer Res
|
2013
|
1.99
|
|
8
|
19p13.1 is a triple-negative-specific breast cancer susceptibility locus.
|
Cancer Res
|
2012
|
1.81
|
|
9
|
Polymorphisms in GSTT1, GSTZ1, and CYP2E1, disinfection by-products, and risk of bladder cancer in Spain.
|
Environ Health Perspect
|
2010
|
1.81
|
|
10
|
Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascade.
|
Cancer Res
|
2010
|
1.51
|
|
11
|
Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer.
|
Cancer Res
|
2009
|
1.43
|
|
12
|
A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3.
|
Hum Mol Genet
|
2011
|
1.36
|
|
13
|
Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk.
|
Proc Natl Acad Sci U S A
|
2012
|
1.36
|
|
14
|
A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European background.
|
Pharmacogenet Genomics
|
2011
|
1.33
|
|
15
|
Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer.
|
Hum Mol Genet
|
2012
|
1.31
|
|
16
|
Assessment of automated image analysis of breast cancer tissue microarrays for epidemiologic studies.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
1.25
|
|
17
|
Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.23
|
|
18
|
The role of genetic breast cancer susceptibility variants as prognostic factors.
|
Hum Mol Genet
|
2012
|
1.23
|
|
19
|
Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers.
|
Breast Cancer Res
|
2012
|
1.16
|
|
20
|
The Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center: a unique resource for defining the "molecular histology" of the breast.
|
Cancer Prev Res (Phila)
|
2012
|
1.15
|
|
21
|
Likelihood ratio test for detecting gene (G)-environment (E) interactions under an additive risk model exploiting G-E independence for case-control data.
|
Am J Epidemiol
|
2012
|
1.14
|
|
22
|
Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC).
|
PLoS One
|
2012
|
1.13
|
|
23
|
Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status.
|
J Med Genet
|
2012
|
1.13
|
|
24
|
Cytoplasmic estrogen receptor in breast cancer.
|
Clin Cancer Res
|
2011
|
1.07
|
|
25
|
Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes.
|
Carcinogenesis
|
2010
|
1.07
|
|
26
|
DNA hypermethylation of ESR1 and PGR in breast cancer: pathologic and epidemiologic associations.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.04
|
|
27
|
Large-scale pathway-based analysis of bladder cancer genome-wide association data from five studies of European background.
|
PLoS One
|
2012
|
1.00
|
|
28
|
A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium.
|
Hum Mol Genet
|
2013
|
1.00
|
|
29
|
TNF polymorphisms and prostate cancer risk.
|
Prostate
|
2008
|
0.95
|
|
30
|
Breast cancer susceptibility risk associations and heterogeneity by E-cadherin tumor tissue expression.
|
Breast Cancer Res Treat
|
2013
|
0.95
|
|
31
|
Breast cancer in Sub-Saharan Africa: opportunities for prevention.
|
Breast Cancer Res Treat
|
2014
|
0.95
|
|
32
|
Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women.
|
Breast Cancer Res Treat
|
2011
|
0.92
|
|
33
|
Polymorphic variants in PTGS2 and prostate cancer risk: results from two large nested case-control studies.
|
Carcinogenesis
|
2007
|
0.90
|
|
34
|
DNA mismatch repair gene MSH6 implicated in determining age at natural menopause.
|
Hum Mol Genet
|
2013
|
0.88
|
|
35
|
Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions.
|
Genet Epidemiol
|
2013
|
0.86
|
|
36
|
A versatile protein microarray platform enabling antibody profiling against denatured proteins.
|
Proteomics Clin Appl
|
2013
|
0.85
|
|
37
|
Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study.
|
Endocr Relat Cancer
|
2013
|
0.83
|
|
38
|
Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland.
|
Breast Cancer Res
|
2011
|
0.83
|
|
39
|
Plasma carotenoid- and retinol-weighted multi-SNP scores and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.81
|
|
40
|
Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer.
|
Breast Cancer Res Treat
|
2012
|
0.81
|
|
41
|
Nonsteroidal anti-inflammatory drugs and other analgesic use and bladder cancer in northern New England.
|
Int J Cancer
|
2012
|
0.80
|
|
42
|
The associations between a polygenic score, reproductive and menstrual risk factors and breast cancer risk.
|
Breast Cancer Res Treat
|
2013
|
0.79
|
|
43
|
Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium.
|
Am J Epidemiol
|
2014
|
0.78
|
|
44
|
Large-scale genotyping identifies a new locus at 22q13.2 associated with female breast size.
|
J Med Genet
|
2013
|
0.78
|
|
45
|
Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study.
|
Menopause
|
2013
|
0.78
|
|
46
|
Prolactin receptor expression and breast cancer: relationships with tumor characteristics among pre- and post-menopausal women in a population-based case-control study from Poland.
|
Horm Cancer
|
2013
|
0.77
|
|
47
|
Unraveling genes, hormones, and breast cancer.
|
J Natl Cancer Inst
|
2012
|
0.77
|
|
48
|
Urinary bisphenol A-glucuronide and postmenopausal breast cancer in Poland.
|
Cancer Causes Control
|
2014
|
0.76
|
|
49
|
Fine mapping of 14q24.1 breast cancer susceptibility locus.
|
Hum Genet
|
2011
|
0.75
|
|
50
|
Corrigendum: Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.
|
Nat Commun
|
2015
|
0.75
|